Top Stories
-
Insomnia accounts for a significantly greater loss of quality of life at the population level than arthritis, obesity, or depressive disorders, a new study from Columbia Psychiatry has found.
Topic
-
For parents struggling with a child's back-to-school anxiety, Columbia University psychologist Anne Marie Albano has some advice.
Topic
-
The brain’s spiny neurons help us make decisions, but without a dose of dopamine at a specific time in childhood, the neurons remain immature.
Topic
-
A Mailman study of more than 1 million pregnancies in Finland reports that prenatal exposure to elevated levels of DDT is associated with an increased risk for autism.
Topic
Latest News
- May 26, 2016
Researchers from Columbia and Finland report an association between maternal nicotine level during pregnancy and increased risk for schizophrenia in children.
- May 20, 2016
Researchers from Harvard and Columbia have found that trauma and PTSD symptoms increase the risk of blood clots in women.
Topic
- May 6, 2016
After a manic episode, adults with bipolar disorder are just as likely to experience anxiety as depression, finds a new Columbia Psychiatry study.
Topic
- April 29, 2016
Use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy is associated with an increased rate of offspring depression, a new study has found.
Topic
- April 19, 2016
Heavy cannabis use may alter the brain's dopamine system, revealing patterns of addiction commonly seen in other types of illicit drug use.
Topic
- April 11, 2016
Columbia researchers have created a new mouse model of anorexia that may reveal new ways to treat the disorder.
Topic
- April 4, 2016
The biomarker is an important step toward understanding and treating one of the most devastating symptoms of schizophrenia.
Topic
- March 31, 2016
Long-acting naltrexone reduced the risk of relapse among people being treated for opioid dependence, a new study reports.
Topic
- March 16, 2016
Researchers from Columbia and the National Institute on Alcohol Abuse and Alcoholism have found that the number of Americans with marijuana use disorder has nearly doubled, but few get treatment.
Topic
- March 11, 2016
Researchers have found that treatment with very low doses of a dopamine-1 receptor (D1R) agonist was not effective in reducing the cognitive and negative symptoms of schizophrenia.
Topic
